Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Genes Immun ; 15(3): 137-44, 2014.
Article in English | MEDLINE | ID: mdl-24500400

ABSTRACT

Activation-induced CD154 expression on CD4 T cells is prolonged in systemic lupus erythematosus, but the mechanism(s) for its dysregulation are unknown. The studies reported herein demonstrate that interleukin-15 (IL-15) is capable of prolonging CD154 expression on phytohemagglutinin (PHA)-activated CD4 T cells. As IL-15 signals through signal transducer and activator of transcription 5 (STAT5), predicted STAT5 binding sites in the human CD154 transcriptional promoter were identified, and STAT5 binding to the proximal CD154 promoter in vitro and in vivo following primary CD4 T-cell activation was demonstrated. Moreover, overexpression of wild-type STAT5 in primary human CD4 T cells augmented CD154 transcription, whereas overexpression of a dominant-negative (DN) STAT5 protein inhibited CD154 transcription. Mutation of the most proximal STAT5 binding site in the CD154 promoter resulted in diminished DNA binding and reduced CD154 transcriptional activity. Interestingly, STAT5-specific small interfering RNA inhibited CD154 surface expression at 48 but not 24 h after T-cell activation. Thus, these findings provide some of the first evidence to support a possible mechanistic link to explain how the overexpression of IL-15 observed in lupus patients may be involved in the prolonged expression of CD154 that has also been observed on lupus CD4 T cells.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , CD40 Ligand/genetics , Interleukin-15/metabolism , Promoter Regions, Genetic , STAT5 Transcription Factor/metabolism , Transcriptional Activation , Adolescent , Binding Sites , CD4-Positive T-Lymphocytes/drug effects , CD40 Ligand/metabolism , Case-Control Studies , Child , Female , Gene Expression Regulation/drug effects , Genes, Reporter , Humans , Interleukin-15/pharmacology , Lupus Erythematosus, Systemic/genetics , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/metabolism , Mutation , Protein Binding , RNA Interference , STAT5 Transcription Factor/genetics , Transcription, Genetic , Transcriptional Activation/drug effects , Up-Regulation
2.
Aust Dent J ; 48(4): 233-9, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14738125

ABSTRACT

In this study we report the use of ultra-short-pulsed near-infrared lasers for precision laser ablation of freshly extracted human teeth. The laser wavelength was approximately 800nm, with pulsewidths of 95 and 150fs, and pulse repetition rates of 1kHz. The laser beam was focused to an approximate diameter of 50microm and was scanned over the tooth surface. The rise in the intrapulpal temperature was monitored by embedded thermocouples, and was shown to remain below 5 degrees C when the tooth was air-cooled during laser treatment. The surface preparation of the ablated teeth, observed by optical and electron microscopy, showed no apparent cracking or heat effects, and the hardness and Raman spectra of the laser-treated enamel were not distinguishable from those of native enamel. This study indicates the potential for ultra-short-pulsed lasers to effect precision ablation of dental enamel.


Subject(s)
Dental Cavity Preparation/instrumentation , Laser Therapy , Bicuspid , Body Temperature , Dental Enamel/diagnostic imaging , Dental Pulp/injuries , Hardness , Hot Temperature , Humans , Microscopy, Electron, Scanning , Spectrum Analysis, Raman , Surface Properties , Ultrasonography
3.
Autoimmunity ; 32(3): 173-80, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11092697

ABSTRACT

CTLA-4 is important to down-regulating T cell responses and has been implicated in type 1 (insulin dependent) diabetes mellitus in both linkage and association studies. The aim of our study was to relate the polymorphic (AT)n microsatellite in the 3' untranslated sequence of the CTLA-4 gene to diabetes risk. We studied 616 consecutively diagnosed 0-34 year-old Swedish patients and 502 matched controls by PCR-based genotyping fo determine the length of the 3'-end (AT)n repeat region of the CTLA-4 gene and categorizing alleles as predominantly monomorphic short (S) or highly polymorphic (in length) long (L) alleles. The odds of type 1 diabetes of subjects with the L/L genotype was estimated to be 1.84 times that of subjects with the S/S genotype (95% CI 1.44-2.73, p=0.002). Further analysis of the long alleles, partitioned into intermediate (I) length and very long (VL) alleles, suggested that L alleles act recessively in conferring diabetes risk (p=0.0009). This study suggests that the 3'-end (AT)n repeat region of the CTLA-4 gene represents a recessive risk factor for type 1 diabetes.


Subject(s)
Antigens, Differentiation/genetics , Diabetes Mellitus, Type 1/genetics , Dinucleotide Repeats , Immunoconjugates , Polymorphism, Genetic , Abatacept , Adolescent , Adult , Alleles , Antigens, CD , CTLA-4 Antigen , Child , Child, Preschool , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans , Infant , Infant, Newborn , Male , Sweden
4.
J Mol Evol ; 42(4): 476-80, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8642618

ABSTRACT

The most generally applicable procedure for obtaining estimates of the symmetrical, or strandnonspecific, directional mutation pressure (microD) on protein-coding DNA sequences is to determine the G+C content at synonymous codon sites (Psyn), and to divide Psyn by twice the arithmetic mean of the G+C content at synonymous codon sites of a large number of randomly generated, synonymously coding DNA sequences (Psyn). Unfortunately, the original procedure yields biased estimates of Psyn and microD and is computationally expensive. We here present a fast procedure for estimating unbiased microD values. The procedure employs direct calculation of Psyn (approximately Psyn) and two normalization procedures, one for Psyn < or = Psyn and another for Psyn > or = Psyn. The normalization removes a bias sometimes caused by codons specifying arginine, asparagine, isoleucine, and leucine. Consequently, comparison of protein-coding genes that are translated using different genetic codes is facilitated.


Subject(s)
Models, Genetic , Mutagenesis/genetics , Proteins/genetics , Animals , Base Composition , Base Sequence , DNA, Mitochondrial/genetics , Entamoeba histolytica/genetics , Giardia lamblia/genetics , Molecular Sequence Data
5.
Cancer Res ; 56(6): 1361-6, 1996 Mar 15.
Article in English | MEDLINE | ID: mdl-8640826

ABSTRACT

Poorly immunogenic tumor cells genetically transduced to simultaneously express the cytokine interleukin 6 (IL-6) and the bacterial metabolic suicide gene cytosine deaminase (205-IL6-CD) become highly immunogenic. They are rejected by normal mice without 5-fluorocytosine prodrug treatment. Mice with preexisting wild-type pulmonary micrometastases exhibit prolonged survival and an increased rate of cure when treated with live 205-IL6-CD cells as a therapeutic vaccine. Treatment with these autologous tumor cells producing both the cytokine and the bacterial protein was more effective than treatment with exogenous IL-6 and/or irradiated wild-type tumor cells. Irradiation of the 205-IL6-CD cells significantly reduced their therapeutic efficacy. Therapeutic vaccination with 205-IL6-CD was more effective in animals with wild-type 205 tumor than in animals bearing an unrelated syngeneic tumor. Vaccine efficacy was significantly reduced in animals pretreated with high-dose cyclophosphamide. The results indicate that genetically engineered autologous tumor vaccines may be capable of inducing significant antitumor immunity in hosts of preexisting micrometastatic disease.


Subject(s)
Fibrosarcoma/secondary , Fibrosarcoma/therapy , Gene Transfer Techniques , Interleukin-6/therapeutic use , Lung Neoplasms/secondary , Lung Neoplasms/therapy , Nucleoside Deaminases/therapeutic use , Vaccines, Synthetic/therapeutic use , Adenocarcinoma/chemically induced , Adenocarcinoma/immunology , Adenocarcinoma/therapy , Animals , Carcinogens , Colonic Neoplasms/chemically induced , Cyclophosphamide/administration & dosage , Cyclophosphamide/pharmacology , Cytosine Deaminase , Dimethylhydrazines , Disease Progression , Female , Fibrosarcoma/chemically induced , Fibrosarcoma/immunology , Fibrosarcoma/metabolism , Fibrosarcoma/mortality , Genetic Vectors , Immunocompromised Host , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/pharmacology , Interleukin-6/genetics , Interleukin-6/metabolism , Interleukin-6/radiation effects , Lung Neoplasms/immunology , Lung Neoplasms/metabolism , Lung Neoplasms/mortality , Methylcholanthrene , Mice , Mice, Inbred C57BL , Nucleoside Deaminases/genetics , Nucleoside Deaminases/metabolism , Nucleoside Deaminases/radiation effects , Tumor Cells, Cultured , Vaccines, Synthetic/immunology , Vaccines, Synthetic/radiation effects
6.
J Mol Evol ; 39(2): 160-73, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7932780

ABSTRACT

We present a new approach for analyzing directional mutation pressure and nucleotide content in protein-coding genes. Directional mutation pressure, the heterogenicity in the likelihood of different nucleotide substitutions, is used to explain the increasing or decreasing guanine-cytosine content (GC%) in DNA and is represented by microD, in agreement with Sueoka (1962, Proc Natl Acad Sci USA 48:582-592). The new method uses simulation to facilitate identification of significant A+T or G+C pressure as well as the comparison of directional mutation pressure among genes, even when they are translated by different genetic codes. We use the method to analyze the evolution of directional mutation pressure and nucleotide content of mitochondrial cytochrome b genes. Results from a survey of 110 taxa indicate that the cytochrome b genes of most taxa are subjected to significant directional mutation pressure and that the gene is subject to A+T pressure in most cases. Only in the anseriform bird Cairina moschata is the cytochrome b gene subject to significant G+C pressure. The GC% at nonsynonymous codon sites decreases proportionately with increasing A+T pressure, and with a slope less than one, indicating a presence of selective constraints. The cytochrome b genes of insects, nematodes, and eumycotes are subject to extreme A+T pressures (microD = 0.123, 0.224, and 0.130) and, in parallel, the GC% of the nonsynonymous codon sites has decreased from about 0.44 in organisms that are not subjected to A+T or G+C pressure to about 0.332, 0.323, and 0.367, respectively. The distribution of taxa according to the GC% at nonsynonymous codon sites and directional mutation pressure supports the notion that variation in these parameters is a phylogenetic component.


Subject(s)
Cytochrome b Group/genetics , DNA, Mitochondrial/genetics , Biological Evolution , DNA Mutational Analysis , Models, Genetic , Point Mutation
7.
Biochem Biophys Res Commun ; 138(2): 803-12, 1986 Jul 31.
Article in English | MEDLINE | ID: mdl-3741435

ABSTRACT

Membrane-alkaline phosphatase shows greater velocity of reaction than solubilized enzyme at low substrate concentration, whereas at saturation-concentration the opposite is true. The catalytic rate enhancement with the membrane-enzyme, when substrate availability is limiting, is attributed to non-specific adsorption of substrate to the membrane followed by its surface-diffusion to the active site resulting in an enhanced collision rate for the substrate with the enzyme. Experimental evidence for the adsorption-diffusion is provided by the dynamic quenching of 1-anilino-naphthalene-8-sulphonate, a membrane-bound probe's fluorescence by the substrate, 4-nitrophenyl-phosphate.


Subject(s)
Alkaline Phosphatase/metabolism , Microvilli/enzymology , Adsorption , Animals , Cell Membrane/enzymology , Diffusion , Intestine, Small/enzymology , Kinetics , Liposomes , Membrane Lipids/physiology , Mice , Proteolipids/metabolism , Spectrometry, Fluorescence
SELECTION OF CITATIONS
SEARCH DETAIL
...